Some argue that this approach will have the untoward consequence that laws are inappropriately mind-dependent in virtue of the account's appeal to the concepts of simplicity, strength and best balance, concepts whose instantiation seems to depend on cognitive abilities, interests, and purposes.
Because starvation causes increased pumping (Avery and Horvitz 1990), this suggests that the mutation might inappropriately activate a starvation-dependent mechanism for exciting the TB.
In vivo, exenatide enhances glucose-dependent insulin secretion, enhances glucose-dependent suppression of inappropriately high glucagon secretion, slows gastric emptying, and reduces food intake.
GLP-1 RAs improve glycaemic control through multiple mechanisms of action including enhancement of glucose-dependent insulin secretion from pancreatic β-cells, glucose-dependent suppression of inappropriately elevated glucagon secretion, slowing the rate of gastric emptying and the absorption of meal-derived glucose, and reducing caloric intake 19– 23.
In contrast, IGT is characterised by reduced peripheral insulin sensitivity, near-normal hepatic insulin sensitivity, progressive loss of beta cell function, reduced secretion of glucose-dependent insulinotropic polypeptide, and inappropriately elevated glucagon secretion [12], [13].
Exenatide stimulates glucose-dependent insulin secretion, suppresses inappropriately high glucagon secretion, slows gastric emptying and reduces food intake [ 3– 7].
Taspoglutide is designed to make therapeutic use of the glucoregulatory properties of GLP-1, which enhances glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon secretion, slows gastric emptying, and reduces food intake [ 1– 3].
"Inappropriate products were sold inappropriately by many.
Molecular-genetic or pharmacological depolarization of GlyCl-expressing cells confers a neoplasia-like phenotype on melanocytes: they overproliferate, become arborized and inappropriately colonize numerous tissues in a metalloprotease-dependent fashion.
Antidiabetic therapies based on glucagon-like peptide-1 (GLP-1) retain the ability of native GLP-1 to stimulate glucose-dependent insulin secretion and suppress inappropriately elevated glucagon secretion (11, 12).
